Literature DB >> 25367853

Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.

Xu Zhou1, Hua-qiang Zhu, Chao-qun Ma, Hong-guang Li, Fang-feng Liu, Hong Chang, Jun Lu.   

Abstract

Hepatocellular carcinoma (HCC) is a prototype of liver cancer, which is closely related to manifested metabolism of lip and glucose. Upstream transcription factor 1 (USF1) is an important transcription factor in human genome, and it regulates the expression of multiple genes associated with lipid and glucose metabolism. This study aims at investigating the correlation between seven common USF1 polymorphisms (i.e., -1994 G>A, -202 G>A, 7998 A>G, -844 C>T, 9042 C>G, 9441 T>C, and -2083 G>A) and the risk of HCC. Elucidation of the interaction might be of vital importance to the diagnosis and prognosis of HCC. One hundred and fifty-five HCC patients and 160 healthy controls from a Chinese Han population were involved in this study. Tag single-nucleotide polymorphisms (SNPs) were identified with reference to CBI-dbSNP and HapMap databases. DNA was extracted from blood samples, and matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was conducted to determine the polymorphisms of USF1. Odds ratio (OR) and 95% confidence interval were applied to evaluate the difference of genotype distribution. Seven SNPs were selected to be representatives. No significant difference was observed concerning -1994 G>A, 7998 A>G, 9042 C>G, 9441 T>C, and -2083 G>A polymorphisms (all P > 0.05). A significantly elevated genotype frequency regarding -202 G>A polymorphism was observed in HCC patients [AA vs. GG: OR 2.13 (1.13-4.01), P = 0.019; AA vs. GG+GA: OR 2.22 (1.32-3.75), P = 0.003; A allele vs. G allele: OR 1.46 (1.07-2.01), P = 0.018]. Subjects carrying mutant -844 C>T genotypes also had a higher risk of HCC [CT vs. CC: OR 1.88 (1.17-3.04), P = 0.009; CT+TT vs. CC: OR 1.83 (1.17-2.86), P = 0.008; T allele vs. C allele: OR 1.49 (1.06-2.09), P = 0.020]. Further studies are recommended to validate our findings in different ethnicity and to clarify the functional relationship between USF1 polymorphisms and the susceptibility of HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367853     DOI: 10.1007/s12032-014-0301-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  24 in total

Review 1.  Novel insights into the pathophysiology of nonalcoholic fatty liver disease.

Authors:  Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

2.  Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene.

Authors:  A Ribeiro; D Pastier; D Kardassis; J Chambaz; P Cardot
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

Review 3.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

Authors:  Wendy Putt; Jutta Palmen; Viviane Nicaud; David-Alexandre Tregouet; Nadia Tahri-Daizadeh; David M Flavell; Steve E Humphries; Philippa J Talmud
Journal:  Hum Mol Genet       Date:  2004-06-02       Impact factor: 6.150

5.  Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Authors:  C Holzapfel; J Baumert; H Grallert; A M Müller; B Thorand; N Khuseyinova; C Herder; C Meisinger; H Hauner; H E Wichmann; W Koenig; T Illig; N Klopp
Journal:  Eur J Endocrinol       Date:  2008-07-01       Impact factor: 6.664

Review 6.  Fatty liver and lipotoxicity.

Authors:  Michael Trauner; Marco Arrese; Martin Wagner
Journal:  Biochim Biophys Acta       Date:  2009-10-24

7.  Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.

Authors:  Pirkka-Pekka Laurila; Jussi Naukkarinen; Kati Kristiansson; Samuli Ripatti; Tuuli Kauttu; Kaisa Silander; Veikko Salomaa; Markus Perola; Pekka J Karhunen; Philip J Barter; Christian Ehnholm; Leena Peltonen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

9.  Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.

Authors:  Jussi Naukkarinen; Emma Nilsson; Heikki A Koistinen; Sanni Söderlund; Valeriya Lyssenko; Allan Vaag; Pernille Poulsen; Leif Groop; Marja-Riitta Taskinen; Leena Peltonen
Journal:  Circ Cardiovasc Genet       Date:  2009-06-12

10.  USF-1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions.

Authors:  Yorann Baron; Sébastien Corre; Nicolas Mouchet; Sophie Vaulont; Sharon Prince; Marie-Dominique Galibert
Journal:  PLoS Genet       Date:  2012-01-26       Impact factor: 5.917

View more
  2 in total

1.  Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis.

Authors:  Di Wang; Jian Zheng; Xiaobai Liu; Yixue Xue; Libo Liu; Jun Ma; Qianru He; Zhen Li; Heng Cai; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-15       Impact factor: 8.886

2.  USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis.

Authors:  Lionel Costa; Sébastien Corre; Valérie Michel; Krysten Le Luel; Julien Fernandes; Jason Ziveri; Gregory Jouvion; Anne Danckaert; Nicolas Mouchet; David Da Silva Barreira; Javier Torres; Margarita Camorlinga; Mario Milco D'Elios; Laurence Fiette; Hilde De Reuse; Marie-Dominique Galibert; Eliette Touati
Journal:  Gut       Date:  2019-12-10       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.